Reference is made to the stock exchange notice by Aqua Bio Technology ASA (the "Company") on 4 December 2018 and 12 February 2019 regarding, inter alia, a private placement (the "Private Placement") and a following subsequent offering with gross proceeds of up to NOK 551,250 through issuance of new shares at a subscription price of NOK 2.50 per share (the "Subsequent Offering"). The investors in the Subsequent Offering will also receive one (1) warrant per share applied for and allocated in the Subsequent Offering. The application period in the Subsequent Offering ended on 28 February 2019 at 16.30 CET. At the end of the application period, the Company had received applications of approximately NOK 302,240 in the Subsequent Offering through subscription of 120,896 new shares. The Company`s board of directors (the "Board") has now allocated shares and warrants in the Subsequent Offering, which implies that the Company will issue 120,896 new shares and 120,896 new warrants related to the Subsequent Offering. Allocation letters, regarding the number of shares and warrants allocated and the subscription amount to be paid, will be distributed to the subscribers shortly. For further information, please call Arvid Lindberg, head of Sales & Marketing, telephone +47 98245410 or arvid@aquabiotech.no (mailto:arvid@aquabiotech.no). Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT`s cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing natural skin care products developed by partners towards consumers and professional users. Aqya Bio Technology is listed on the Axess market of the Oslo Stock Exchange. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. ??
Recent Comments